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A NATION TRANQUILZED-A SOCIO-LEGAL
ANALYSIS OF THE ABUSE OF SEDATIVES
IN THE UNITED STATES
GERALD T. McLAUGHLIN*
IJNTIL quite recently, the abuse' of sedatives in the United States was
a "neglected area" of study." The primary emphasis in drug treat-
ment and prevention was always with the so-called "narcotic drugs" such
as heroin, cocaine and marihuana.3 For example, the United States Public
Health Service hospitals at Lexington, Kentucky and Fort Worth, Texas
-for years the primary drug research and treatment centers in the coun-
try-would not accept barbiturate addicts unless they also happened to
be habitual users of opiates, cocaine or marihuana.4 The emphasis, how-
ever, is beginning to shift. The reasons for the change in priorities are not
difficult to discover.
In 1972, there were reports that parts of California were "virtually
flooded" with illicit barbiturate capsules.5 A statewide survey in New
York demonstrated that over one half million people fourteen years or
older-ten percent of whom obtained their drugs illegally-used sedatives
on a consistent basis.6 Statistics published in 1973 by the National Com-
mission on Marihuana and Drug Abuse indicate that abuse of depressants
is not confined to any one region of the country but is truly a national
* Associate Professor of Law, Fordham University School of Law. Professor McLaughlin
received his B.A. from Fordham College and his LL.B. from New York University.
1. In this article, abuse of sedative means the self-administration of these drugs without
the supervision of a doctor.
2. Ingersoll, Drug Abuse in Contemporary America, 7 J. Cal. L. Enforcement 22 (1972)
[hereinafter cited as Ingersoll].
3. It must be realized that the legal definition of a narcotic drug is different from the
pharmocological definition. In the pharmocological sense, a narcotic drug is one that de-
presses the central nervous system, producing stupor, insensibility or sleep. Upton, Narcotics
and Other Drugs Susceptible to Abuse, and Their Regulation, 10 N.H.B.J. 264, 265 (1968).
According to this definition, cocaine (a stimulant) and marihuana (a mild hallucinogenic)
would not be considered narcotics. Under the legal definition of a narcotic drug, however,
were included various socially disapproved drugs regardless of their pharmocological prop-
erties. Thus, American drug laws generally define cocaine and marihuana as narcotic drugs.
See Drug Use in America: Problem in Perspective, Second Report of the National Commis-
sion on Marihuana and Drug Abuse 16-17 (1973) [hereinafter cited as National Com-
mission-Second Report].
4. H. Anslinger & W. Tompkins, The Traffic in Narcotics 123 (1953).
S. Ingersoll 22.
6. Chambers, Brill & Inciardi, Toward Understanding and Managing Nonnarcotic Drug
Abusers, 36 Fed. Prob., Mar. 1972, at 50 [hereinafter cited as Chambers, Brill & Inciardi]
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problem. An estimated ten percent of the adult population and six percent
of those between twelve and seventeen years of age have used a prescrip-
tion sedative for non-medical purposes.7 If those who used over-the-
counter sedatives for non-medical purposes were included, the percentage
would be substantially higher.8 When compared to the incidence of other
forms of drug abuse, the Commission's figures show that the abuse of
depressants is approximately eight times more common than the abuse
of heroin, three times more common than the abuse of cocaine and twice
as common as the abuse of amphetamines.' In addition to this enormous
illicit consumption, there are an estimated 150,000,000 prescriptions
written every year for sedatives and tranquilizers.' 0 With such a large
national market, annual production of barbiturates is estimated to be
1,000,000 pounds, enough to provide every American with twenty-four
one-and-one-half grain doses.1" These statistics become more frightening
when one considers that barbiturates (and possibly other forms of de-
pressants) "are potentially the most lethal of all abused drugs.' 2
In his testimony before a Senate subcommittee studying juvenile de-
linquency, Dr. Sidney Cohen best summarized the recent increase in
sedative abuse: "If 1966 was the year of acid, 1968 the year of speed, and
1970 the year of smack-heroin, then 1972 may well become the year of
the downer.... [D]owners seem to be coming on fast, especially among
the very young. ' n3
As with many topics in the field of drug abuse, the legal literature on
the subject of the abuse of depressants is minimal.1 4 In light of the mag-
nitude of the problem, there is need for a comprehensive analysis of the
nature and characteristics of the abuse of sedatives in the United States
and the legal controls enacted to regulate that abuse. To that end, Part I
of this article will classify the various depressants and indicate the dan-
gers to personal and public health and safety inherent in their widespread
abuse. Part II will trace the development of legal controls over the use of
7. National Commission-Second Report 63 (Table 11-20).
8. Id.
9. Id.
10. Id. at 43. The Commission states that in 1970 there were 214 million prescriptions
written for psychoactive drugs; 67.4 percent of these were for barbiturates and tranquilizers.
11. Chambers, Brill & Inciardi 50.
12. Ognibene, Legal Drugs, Illegal Abuse-Amphetamines and Barbiturates, 168 New
Republic, Feb. 3, 1973, at 21, 22. V
13. Hearings on Barbiturate Abuse Before the Subcomm. to Investigate Juvenile Delin-
quency of the Senate Comm. on the Judiciary, 92d Cong., 1st & 2d Sess. 71 (1971) (State-
ment of Professor Sidney Cohen, M.D.) [hereinafter cited as Subcomm. Hearings].
14. Perhaps the best article on the history of depressant legislation in the United States
is Rosenthal, Dangerous Drug Legislation in the United States: Recommendations and Com-
ments, 45 Texas L. Rev. 1037 (1967).
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sedatives, with particular emphasis on recent statutory and regulatory
changes.
I. DESCRIPTION OF DEPRESSANTS
A. The History of Sedative Use in the United States
For the purposes of analysis, the terms "sedative" and "depressant"
should be given a precise definition. Included in that definition are bas-
ically four categories of drugs: a) those sedatives such as potassium bro-
mide, chloral hydrate and paraldehyde which enjoyed wide popularity in
the late nineteenth century; b) the barbiturates which were first used in
medical practice in 1903; c) the tranquilizers which were introduced into
clinical practice in the 1950s; and finally, d) methaqualone, a popular
modem depressant which does not fit neatly into the category of either a
barbiturate or a tranquilizer.'" The various drugs in each of these four
categories share one basic similarity-they all depress the central nervous
system and consequently are referred to in drug parlance as "downers."
No one should imagine, however, that all of the drugs to be discussed are
similar in every respect. Each drug produces varying side effects and thus
has its own precise medical usage.
1. Chloral Hydrate and Other Nineteenth Century Sedatives
During the late nineteenth century, various chemicals were widely
marketed as cures for nervous disorders. The bromides, which were in-
troduced during the 1850s, were the first group of drugs used to treat
nervous upsets and later to control epilepsy."0 The oldest of the bromides,
potassium bromide, was allegedly used by millions of Americans, par-
ticularly in the western part of the United States." Continued use of
potassium bromide, however, could result in serious side effects such as
delusions, coma and possibly death.' 8
Although first synthesized by the German chemist Justus von Liebig in
1832, chloral hydrate was not introduced into medicine until 1869.11 Like
potassium bromide, it could also produce unpleasant side effects and as a
15. Purposely excluded from this definition and therefore from discussion in this article,
are various proprietary or over-the-counter sedatives and tranquilizers. Without doubt,
these compounds are also the subject of abuse. For the names of the more common over-the-
counter sedatives and tranquilizers see National Commission-Second Report So n.3.
16. A. Grollman & E. GroUman, Pharmacology and Therapeutics 16S (7th ed. 1970)
[hereinafter cited as Grollman].
17. J. Fort, The Pleasure Seekers: The Drug Crisis, Youth and Society 25 (1969) [herein-
after cited as Fort].
18. Id. at 163.
19. Grollman 171.
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result was replaced in medical practice by newer and supposedly less
toxic sedatives such as the barbiturates.2 ° Chloral hydrate perhaps re-
ceived its greatest notoriety as an ingredient of a "Mickey Finn." These
infamous knockout drops combined chloral hydrate with the synergistic
effects of alcohol.21
Paraldehyde entered the medical pharmacopoeia in 1882, thirteen years
after chloral hydrate. 2 Even though it had an unusually pungent taste,23
paraldehyde did rank among the most popular early sleeping medicines.
Although still used today in certain medical treatments, 4 there is a good
deal of uncertainty about exactly how paraldehyde affects the human
body.25 A fourth early sedative, scopolamine (which is still an ingredient
in certain proprietary sleeping remedies) was the forerunner of modern-
day "truth serums. 26 Scopolamine was first used by a Texas physician in
the 1920s to develop a psychoanalytical technique called narcoanalysis.27
These early studies disclosed that verbal responses could be obtained from
otherwise uncommunicative subjects. During the 1930s and World War
II, however, psychiatrists turned more to barbiturates (such as sodium
amytal and sodium pentothal) when they wished to obtain "truthful" un-
inhibited responses during psychotherapy.28
2. Barbiturates
Barbituric acid was first synthesized by the German organic chemist
Adolf von Baeyer in 1863.29 Although the derivation of the word "bar-
biturate" is still the subject of controversy, it has been argued that von
Baeyer named it after St. Barbara on whose feast day he synthesized the
20. See generally P. Weston, W. Kessler, F. Farrell, R. Fisher, J. Dumpson, R. Radna,
M. Nealis, J. Belson & H. Houghton, Narcotics, U.S.A. 90 (P. Weston ed. 1952).
21. R. Lingeman, Drugs from A to Z: A Dictionary 40 (1969) (hereinafter cited as
Lingeman].
22. Fort 25.
23. Subcomm. Hearings 1170 (citing AMA Drug Evaluations).
24. For example, it is often used to induce sleep when alcoholics are in delerium tremens.
Lingeman 195.
25. For example, the lethal dose of paraldehyde is unknown. Id. See also Fort 164-65.
26. On the subject of the admissibility of drug-induced confessions see Despres, Legal As-
pects of Drug-Induced Statements, 14 U. Chi. L. Rev. 601 (1947) [hereinafter cited as Des-
pres]; Dession, Freedman, Donnelly & Redlich, Drug-Induced Revelation and Criminal
Investigation, 62 Yale L.J. 315 (1953) [hereinafter cited as Dession].
27. Despres 602-03.
28. Despres 603-04; Dession 317. These drugs, however, do not necessarily elicit the
truth. Bieser, Drugs and the Law or Who Pays for the "Trip"?, 36 U. Cin. L. Rev. 39, 44
(1967) ; Despres 606.
29. D. Maurer & V. Vogel, Narcotics and Narcotics Addiction 102 (3d ed. 1967). Some say
von Baeyer made the synthesis one year earlier. 83 Time, Jan. 3, 1964, at 48.
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compound3 Although barbituric acid itself has no effect on the central
nervous system,31 its various derivatives comprise one of the largest group
of sedatives presently marketed. The first barbituric acid derivative was
synthesized in 1903 by Fischer and von Mering 2 Called Veronal, 33 the
drug was followed in quick succession by Luminal in 191214 and there-
after by many other barbiturate derivatives. It has been estimated that
as many as 2,500 barbituric acid derivatives have been synthesized, al-
though only about twenty-five are used in medical prescriptions05
Barbiturates can be divided into four categories depending on the onset
and duration of their effects.3 The first category-the long acting bar-
biturates-include the oldest of the barbiturate derivatives, barbital
(Veronal) and phenobarbital (Luminal). Drugs in this category take
some time before their effects are felt, but once felt, they last for a com-
paratively long time. The prolonged effect of these drugs is due to their
rather slow elimination through the kidneys? 7 In some cases, long acting
30. Maurer & Vogel, supra note 29, at 102; 83 Time, Jan. 3, 1964, at 48. Various other
more secular explanations have been offered for the choice of the name. One medical writer
argued that when von Baeyer used the word "barbitursaure" to name the compound, he
was combining the German word "schijsselbart" (meaning the "beard" of a key and de-
rived from the Latin for beard, "barba") and uric acid "so as to stress his conception
of this substance as the key compound in the large series of cyclic ureides." Levi, The
Barbituric Adds, Their Chemical Structure, Synthesis and Nomenclature, 9 U.N. Bull.
Narc., Jan.-Mar. 1957, at 30. Others claim that the synthesis was named after a Munich
waitress named Barbara who supplied urine samples for von Baeyer's experiments. Some
think Barbara the waitress was in fact von Baeyer's mistress. 83 Time, Jan. 3, 1964, at 48.
See also Levi, The Barbituric Adds, Their Chemical Structure, Synthesis and Nomen-
clature, 9 U.N. Bull. Narc., Jan.-Mar. 1957, at 30.
31. Bureau of Narcotics and Dangerous Drugs, U.S. Dep't of Justice, A Study of Cur-
rent Abuse and Abuse Potential of the Sedative-Hypnotic Derivatives of Barbiturate Add
with Control Recommendations [hereinafter cited as BNDD Report], in N.Y. Interim Rep.
of Temporary State Comm'n to Evaluate the Drug Laws, Drugs and Drug Penalties Under
Review: A Documentary Study 79, 88 (1973) [hereinafter cited as Drugs and Drug Penalties
Under Review].
32. Groilman 160.
33. It is alleged that Fischer worked out the chemical structure of Veronal while
stopped on a train in Verona, Italy. R. De Ropp, Drugs and the Mind 162 (1957). Another
suggested explanation for the choice of the name is that Verona was the first city where
the new drug was tested. New Remedial Agents, The Ureide Hypnotics, 100 Am. J. Pharm.
692 (1928).
34. See Subcomm. Hearings 1173 (citing Sharpless, The Barbiturates, In The Phar-
macological Basis of Therapeutics 105 (3d ed. L. Goodman & A. Gilman 1965)).
35. BNDD Report 88.
36. Id. at 92. Some analysts divide the barbiturates into only three categories. See Linge-
man, supra note 21, at 19. See also Maurer & Vogel, supra note 29, at 104-05.
37. 108 Am. J. Pharm. 39 (1936).
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barbiturates often linger in human muscle or fat tissue long after their
effects on the central nervous system have disappeared."8 For example,
traces of barbital have been discovered in tissue eight to twelve days after
ingestion. 9 One of these long acting barbiturates-phenobarbital-is the
most commonly prescribed barbiturate, accounting for over one half of
all American barbiturate sales.4" Intermediate-acting barbiturates take
effect faster but have a shorter duration than the long acting barbiturates.
Because they are metabolized rather rapidly, these intermediate-acting
drugs have the advantage of not causing any lingering barbiturate hang-
over. Included in this category of barbiturates are pentobarbital (Nem-
butal) and amobarbital (Amytal). The short-acting barbiturates take
effect even faster than the intermediate-acting drugs but they last a much
shorter time. Secobarbital is the most common short-acting barbiturate.
It is both the intermediate- and short-acting barbiturates that are most
sought after by the drug taker.
If the potency of a drug is too great and its effects are felt too fast, as in the case
of... ultra-fast-acting barbiturates, the abuser cannot obtain pleasure from non-medical
use; he is asleep before he realizes it. On the other hand, if the onset of effects is
delayed too long after administration, the abuser may not obtain the desired feelings
soon enough to satisfy himself.41
As for the ultra-short acting barbiturates, the most widely used of these
drugs is thiopental (Pentothal).
From the very first year of their medical use, barbiturates were widely
proclaimed by physicians to be a relatively safe form of sedation. But
even then there were early danger signs. A nonfatal barbiturate poisoning
was reported in the German medical press in 1903-the very year Veronal
first appeared on the market.4 ' Five years later, in 1908, there was a re-
port of a fatal Veronal poisoning.4" One English report confirmed that
Veronal was the seventh ranked cause of fatal poisonings during 1911 to
1913. 4 In succeeding decades, studies showed that, taken in excessive
amounts, barbiturates could be both highly toxic and addicting.4" Despite
38. P. Matin & A. Cohen, Understanding Drug Use 104 (1971).
39. Id.
40. Subcomm. Hearings 103 (testimony of Dr. H. Frank Fraser).
41. BNDD Report 93. The most abused barbiturates are amobarbital, pentobarbital and
secobarbital. Subcomm. Hearings 103 (testimony of Dr. H. Frank Fraser).
42. Glatt, The Abuse of Barbiturates in the United Kingdom, 14 U.N. Bull. Narc., Apr.-
June 1962, at 19.
43. Id.
44. Id.
45. See notes 109-36 infra and accompanying text.
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the dangers of abuse,40 barbiturates are still believed to be extremely
effective when taken under medical supervision.
3. Tranquilizers
When compared to barbiturates, tranquilizers usually produce much
milder effects on the central nervous system. In most situations, tran-
quilizers will neither make a person groggy nor induce him to fall asleep
as do the barbiturates47
The first tranquilizer actively used in western medicine seems to have
been reserpine. Although synthesized in Switzerland in 1947, the dis-
covery that reserpine was useful in the treatment of mental illness relied
on research done earlier in India. In 1931, Indian scientists discovered
that rauwolfia reduced blood pressure and hypertension. 8 From this re-
search, it was a short step to the discovery that reserpine, an alkaloid of
rauwolfia, could be used in the successful treatment of mental disorders.40
As in the case of barbiturates, the introduction of reserpine into clinical
practice was followed in rapid order by other tranquilizers. In 1954, glu-
tethimide was marketed under the name Doriden.5 In but a few years the
manufacturer of Doriden claimed that over one billion capsules had been
sold.51 Although initially acclaimed as a "safe" sedative, the euphoria was
short-lived as evidence mounted that Doriden was equally as dangerous
as other sedatives."2 A second tranquilizing agent-meprobamate--ap-
peared in 1955 under the name of Miltown and later Equanil. Like Dor-
iden, Miltown met initial popularity, then disillusionment. As controversy
46. One physician saw possible national security risks in widespread sedative use:
"Fortunately, controls are being placed and public warning is being given to America by
people who recognize the danger of a tranquilized Nation, men who know from history
that it was a tranquilized Babylon who sat in a drunken stupor of self-indulgence while an
alert group of Medes and Persians crept under their walls and destroyed them." Joint
Committee of the ABA and the AMA on Narcotic Drugs, Comments on Narcotic Drugs 35
(1958).
47. Lingeman 238.
48. See generally Blum, Mind Altering Drugs (LSD, Marijuana, Hashish, etc.): A Sci-
entific Appraisal, 21 Unesco Courier, May 1968, at 13, 14.
49. Id.
50. Although a tranquilizer and not a barbiturate, glutethimide resembles phenobarbital
in chemical structure and secobarbital in its effects. Lingeman 84.
51. Fort 165.
52. Id.
53. 85 Time, Apr. 30, 1965, at 85. At one time there were approximately 20 meprobamate
drugs on the market. 87 Sci. News 69 (1965).
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over its effectiveness spread, Miltown was dropped from the official United
States Pharmacopoeia in 1965.14
Two more recent tranquilizers warrant some mention. Chlordiazepoxide
(Librium) has been in medical use since 1960 and by 1966 an estimated
fifteen million patients had used the drug."' Librium is primarily used to
treat mild cases of anxiety; sometimes it is also used to reduce pre-surgery
apprehension. 6 Diazepam (Valium) came into widespread use in 1963.
Three years later it had been dispensed to an estimated five million pa-
tients. 57 Valium has medical uses similar to those of Librium although it
may have somewhat more benefit in the treatment of neuromuscular or
musculoskeletal disorders. 8
For purposes of pharmacological classification, tranquilizers are usually
divided into two groups: major tranquilizers and minor tranquilizers.
These terms refer to the relative strength of the drugs and to their poten-
tial for causing toxic reactions."9 Thus, the major tranquilizers (such as
chlorpromazine and reserpine) are highly potent and toxic and are used
only in the treatment of acute forms of mental illness such as schizo-
phrenia. The minor tranquilizers (glutethimide chlordiazepoxide and
diazepam among others) are relatively less potent and toxic than the
major tranquilizers with the result that they are prescribed for treatment
of less severe forms of anxiety and nervous tension."'
4. Methaqualone
Although not available to American physicians until 1965, methaqua-
lone became popular in Western Europe and Japan in the early and mid
1960s."2 Sold under various names such as Quaalude, Sopor, Parest and
Optimil, methaqualone prescriptions grew to approximately four million
in 1972, making it one of the most widely used sedatives in the United
54. 85 Time, Apr. 30, 1965, at 85. Even though dropped from the pharmacopoeia, Multown
was still available to doctors for prescriptions.
55. Hoffman-La Roche, Inc. v. Kleindienst, 478 F.2d 1, 4 (3d Cir. 1973).
56. Lingeman 126.
57. Hoffman-La Roche, Inc. v. Kleindienst, 478 F.2d 1, 4 (3d Cir. 1973).
58. Subcomm. Hearings 764 (citing AMA Drug Evaluations).
59. Packman, Tranquilizers, 140 Am. J. Pharm. 170 (1968).
60. Id. Chlorpromazine, one of the first major tranquilizers, was known in the United
States as Thorazine and in Europe as Largactil. Fort 171.
61. Packman, supra note 59, at 170.
62. Bureau of Narcotics and Dangerous Drugs, U.S. Dep't of Justice, Control Recommen-
dations for Methaqualone [hereinafter cited as BNDD Methaqualone Report], In Drugs and
Drug Penalties Under Review 39, 42, 53. Methaqualone was first introduced in India in 1950.
National Clearing House for Drug Abuse Information, Methaqualone I (Report Series 18,
No. 1, Oct. 1973).
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States. 3 Paralleling this increased legitimate use, there are indications
that there is mounting illegitimate use of methaqualone, so much so that
a recent magazine article claimed that methaqualone abuse is growing
faster than that of any other drug." In New York City, quaalude clubs or
"juice bars" have appeared "which cater to users of the drug, and appro-
priately serve juice to take with the pills, rather than alcoholic beverages,
which can intensify the drug's effects and increase the chances of over-
dose."65 Police statistics also demonstrate this increased methaqualone
use. For example, the District Attorney of Nassau County in New York
State reports that there were 21 cases of methaqualone overdose in the
county during 1972.66 A survey of patients at a San Francisco drug clinic
shows that of patients recently detoxified, 35 percent admitted having
used the drug---all quite recently.67 Although it is difficult to account for
the sudden popularity of various drugs among addicts and abusers, meth-
aqualone may owe its sudden emergence on the drug scene to reports that
it is an aphrodisiac." In popular drug folklore, methaqualone has been
proclaimed as "the love drug" and as "heroin for lovers.""0
B. The Use and Abuse of Sedatives
1. Legitimate Medical Use
Although all sedatives have a wide range of legitimate medical uses, the
barbiturates are perhaps the most varied in their application. Barbiturates
have three main clinical uses-as anesthetics, as sedatives, and as anti-
convulsants.
63. Ognibene, There's Gold in Them There Pills, 168 New Republic, Apr. 21, 1973, at 13,
14; 74 US. News & World Rep., Apr. 23, 1973, at 59, 60.
64. 74 U.S. News & World Rep., Apr. 23, 1973, at 60.
65. National Clearing House for Drug Abuse Information, supra note 62, at 3.
66. Drugs and Drug Penalties Under Review 21.
67. Ognibene, There's Gold in Them There Pills, 168 New Republic, Apr. 21, 1973, at 14.
68. National Clearinghouse for Drug Abuse Information, supra note 62, at 3-4.
69. BNDD Methaqualone Report 62; 74 U.S. News & World Rep., Apr. 23, 1973, at 60.
Various other drugs have also been described as aphrodisiacs. Cocaine reputedly stimulates
sexual desire and gives the male greater potency. See M. Olden, Cocaine passim (1973);
House Comm. on Foreign Affairs, 93d Cong., 1st Sess., Report of Special Study Mision to
Latin America and the Federal Republic of Germany 8-9 (Comm. Print 1973); McLaughlin,
Cocaine: The History and Regulation of a Dangerous Drug, 58 Cornell L. Rev. 537, 556
(1973). Marihuana, LSD, and various solvents inhaled by juvenile drug abusers have also
been associated with increased sexual stimulation. Nakamura & Adler, Psychotoxic or Psy-
chedelic?, 63 J. Crim. L.C. & P.S. 416, 423 (1972). There may not be a physiological basis to
such associations; rather, they may have arisen because these drugs may lower inhibitions and
dissolve the superego. Id. Heroin, a depressant, would not seem to stimulate sexual desire,
but excessive amounts of depressants may have paradoxically reverse reactions.
1974]
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a. Barbiturates as Anesthetics
If taken in large enough quantities, barbiturates will render a person
unconscious, thus making them effective where general anesthesia is re-
quired."0 Dentists and oral surgeons often use ultra-fast-acting barbitur-
ates to pull teeth or treat severe gum or jaw injuries.7 In situations where
surgery is called for, barbiturates can be used as pre-anesthetic medica-
tion if a doctor feels that a person's tension may endanger his post-opera-
tive recovery.72
b. Barbiturates as Sedatives
Perhaps the most widespread use of barbiturates is in the treatment of
insomnia.73 Taken in sufficient doses, barbiturates will generally induce
sleep. The fact that smaller doses of barbiturates mildly depress the
nerves, skeletal and heart muscles, and lower blood pressure, 4 makes
them ideal anti-anxiety agents. Combined with other drugs, barbiturates
frequently serve as medicine for such ailments as gastric ulcers, thyroid
malfunction, asthma, and hay fever.7 5 Although not strong analgesic
drugs, barbiturates are sometimes prescribed for menstrual pains.7'
c. Barbiturates as Anti-convulsants
Phenobarbital is commonly administered in cases of grand mal epileptic
seizures.7 Barbiturates are also used to control bodily spasms in other
situations where convulsions develop." In addition to their broad appli-
cation in human medicine, barbiturates have many uses in veterinary
practice, particularly for anesthesia and euthanasia.70
Although it may not be wise to draw precise delineations between the
medical uses of barbiturates and the minor tranquilizers, it does seem that
these tranquilizers are more widely prescribed for daytime sedation when
there is a need to reduce tension but not mental acuity.80 The major tran-
70. BNDD Report 109.
71. Subcomm. Hearings, supra note 13, at 108.
72. BNDD Report 110.
73. Subcomm. Hearings 108.
74. Amphetamines and Barbiturates: The Up and Down Drugs, 58 Today's Educ., Mar.
1969, at 42, 44. Barbiturate sedatives have many uses in psychotherapy.
75. Maurer & Vogel, supra note 29, at 103.
76. Id.
77. Subcomm. Hearings 109.
78. BNDD Report 110.
79. Although not the most common anesthetic in human surgery, it may be in animal
surgery. Hearing Before the Subcomm. on Drug Abuse and Alcoholism of the Comm. on
Health and Welfare, Cal. Legis. Assembly, at 75 (1969) [hereinafter cited as California
Hearing].
80. See Lingeman, supra note 21, at 238. Some would dispute that minor tranquilizers
are more effective in daytime sedation than small amounts of barbiturates. Id. at 169. See
[Vol. 42
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quilizers are used almost exclusively in the treatment of severe mental
disturbances.8' One major tranquilizer, chlorpromazine, has also been
used to reduce the unusual visual effects of hallucinogenic drugs.'
Methaqualone, a non-barbiturate, while sometimes prescribed for day-
time sedation, is used primarily to treat insomnia.83 It supposedly will
induce sleep within ten to thirty minutes."' Because it also has certain
antitussive and antispasmodic characteristics, methaqualone may be par-
ticularly useful when insomnia is aggravated by coughing or by gastro-
intestinal distress.85 However, methaqualone is not recommended for chil-
dren or for pregnant women.86
2. Illegitimate Abuse
Those who abuse barbiturates will generally do so for a variety of
reasons-some will take increased amounts of barbiturates to keep calm
under emotional stress. Paradoxically, others will take the drug not to
calm but to stimulate; when a sufficient tolerance level has been reached,
barbiturates may produce reverse bodily reactions and excite rather than
depress. A third group of individuals may employ barbiturates either to
counteract or to enhance the effects of other drugs. Finally, there are
those who will take barbiturates in order to commit suicide." In discuss-
ing the various ways in which barbiturates are abused, primary emphasis
will be placed on those individuals who use barbiturates either in com-
bination with other drugs or to obtain excitatory reactions.
As has already been noted, most abusers prefer an intermediate- to
short-acting barbiturate because of the prompt onset of effects.! The
strength of these effects, however, is significantly influenced not only by
the amount of the drug taken, but also by the mood of the person taking
the drug and the social setting in which he finds himself.8 9 This explains
also 81 Sci. News 312 (1962). Valium, a minor tranquilizer and skeletal-muscle relaxant, has
been known to relieve the rare "stiff-man's syndrome." Roueche, Annals of Medicine, The
Case of Mrs. Carter, 44 New Yorker, Dec. 7, 1968, at 207, 224.
81. See note 61 supra and accompanying text.
82. Hussar, Therapeutic Incompatibilities: Drug Interactions, 139 Am. J. Pharm. 215,
224 (1967). See also Halasz, Formanek & Marrazzi, Hallucinogen-Tranquilizer Interaction:
Its Nature, 164 Science 69 (1969). In some cases, tranquilizers may aggravate hallucino-
genic action, however. Id. at 571. Chlorpromazine reportedly can also cause slight changes
in the eye lenses of patients. 89 Sci. News 235 (1966).
83. Drugs and Drug Penalties Under Review, supra note 66, at 26.
84. Sedam & Tice, New Drugs of 1965 and 1966, 139 Am. J. Pharm. 47, 64 (1967).
85. Id.
86. Drugs and Drug Penalties Under Review, supra note 66, at 26; National Clearing-
house for Drug Abuse Information, supra note 62, at 5.
87. Chambers, Brill & Inciardi, supra note 6, at 50-51. Paraldehyde and chloral hydrate
are not widely abused drugs. Subcomm. Hearings, supra note 13, at 1230.
88. See text accompanying note 41 supra.
89. R. Blum & M. Funkhouser-Balbaky, Mind-Altering Drugs and Dangerous Behavior:
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the rather unusual custom of taking sleeping pills before going to a
partyY0
Small amounts of barbiturates like small amounts of alcohol will reduce
fear and anxiety, making the individual less inhibited. Although his in-
hibitions may be reduced, the individual's ability to carry out complex
tasks which require either mental or physical dexterity is also reduced.0 1
As the dose of barbiturates is increased, the intoxication experienced will
become progressively more heightened. Lack of muscle coordination,
faulty articulation and judgment all result from the barbiturate "high." '0
It is this state of "dreamy, floating ... awayness untroubled by reality"
that may appeal to juvenile barbiturate users." Sometimes of course these
large doses of barbiturates may increase belligerency or irritability in a
person. Adolescent youths may "drop a roll of them reds (seconal) or
yellow jackets (nembutal) and go out terrorizing .... As the barbitu-
rate dose begins to approach toxic levels, an individual will experience
dreamlike states with periods of unconsciousness and even coma.05 Para-
noid delusions and violent outbursts may also occur in this highly drugged
state. 96 Finally, if the dosage is excessively large, barbiturates will depress
the respiratory centers of the brain so completely that death will result.0 7
Since tranquilizers tend to be milder sedatives than the barbiturates,
they do not seem to be preferred drugs of abuse.98 For example, the major
Dangerous Drugs in President's Commission on Law Enforcement and Administration of
Justice, Task Force Report: Narcotics and Drug Abuse 22-23 (1967). See also BNDD Report
106.
90. BNDD Report 106-07.
91. Id. at 105. Small amounts of barbiturates can obviously affect a man's ability to
drive a car. Id. at 106.
92. Subcomm. Hearings 109-10.
93. Id. at 71.
94. H. Blumer, The World of Youthful Drug Use 25 (1967). Various types of barbi-
turates have acquired street names usually from the color of their capsules. Nembutal pills
are called yellow jackets or nebbies; Seconal, reds, red birds, or red devils; Amytal Sodium,
blues, blue birds, blue heavens, or blue devils; Luminal, purple hearts; and Tuinal, rainbows
or reds and blues. See generally E. Brecher, Licit & Illicit Drugs, The Consumers Union
Report on Narcotics, Stimulants, Depressants, Inhalants, Hallucinogens and Marihuana-
Including Caffeine, Nicotine, and Alcohol (1972); Lingeman, supra -note 21, passim.
95. H. Blumer, supra note 94, at 83; BNDD Report 107.
96. H. Blumer, supra note 94, at 83.
97. BNDD Report 107. Death through respiratory depression, however, is not unique
in cases of barbiturate poisoning. Excessive amounts of any drug which is a stimulant or a
depressant will cause similar reactions. Lynch, The Pharmacology of Addicting Drugs, 12
Catholic Law. 121, 123 (1966). Barbiturate poisoning is detectable by determining the pres-
ence of barbituric acid in either the blood or the urine. Grollman, supra note 16, at 166.
98. Because of their relative newness, however, there is much less research data on
various types of tranquilizers. Tranquilizer abuse may be just as widespread as barbiturate
abuse only, as yet, not adequately analyzed.
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tranquilizers used to treat severe psychotic disorders appear not to be
taken for other than medical reasons." The same cannot be said for the
minor tranquilizers. If taken in medically prescribed doses, most minor
tranquilizers will not produce a feeling of elation or a euphoric "high."
With increased doses, however, there is some medical evidence that eu-
phoria may result from the use of Librium and Valium-two of the most
popular minor tranquilizers. 10 Whether or not minor tranquilizers do
cause a "high,"' there seems to be growing evidence that some people
do attempt to use them for this purpose.0 2
If there is dispute over whether these minor tranquilizers produce eu-
phoria, there is significantly less dispute over the fact that they, like the
barbiturates, can affect a person's judgment and physical dexterity. For
example, as early as 1960, large doses of Librium were reported to pro-
duce disturbing reactions. 03 One man who was taking a larger than aver-
age dose of Librium allegedly put his car into reverse and crashed it into
a tree at fifteen miles per hour.' 4
When taken in doses larger than those recommended by doctors, meth-
aqualone will produce effects similar in most respects to those of the bar-
biturates. 05 The effects have been described as "dream-like" and "eu-
phoric."'0 6 There is evidence, however, that a methaqualone high has a
more rapid onset and lasts comparatively longer than that of other seda-
tives-including many of the more widely abused barbiturates 07 Mixed
with alcohol, methaqualone reportedly causes hallucinatory sensations.
3. Dependence08
"Down" drugs cause a physical dependence not observed with "up"
99. E. Brecher, supra note 94, at 257; Subcomm. Hearings, supra note 13, at 1023.
100. See Hoffman-La Roche, Inc. v. Kleindienst, 478 F.2d 1 (3d Cir. 1973). The court,
however, characterized the evidence as neither very ample nor very persuasive. Id. at 10.
101. See 91 Sci. News 232-33 (1967).
102. For mention of Librium abuse among "hippies" and "Hell's Angels," see A. Cain,
Young People and Drugs 46 (1969).
103. 75 Time, May 30, 1960, at 37.
104. Id.
105. For a description of methaqualone's effects, see National Clearinghouse for Drug
Abuse Information, supra note 62, at 4.
106. BNDD Methaqualone Report 61. Some individuals who use the drug show their
approval by wearing shirts marked with one manufacturer's initials. Id. at 61-62.
107. For example, methaqualone produces its effects within 15 to 30 minutes after in-
gestion and lasts for approximately six to ten hours. Drugs and Drug Penalties Under Re-
view, supra note 66, at 20-21. Intermediate-acting barbiturates such as Nembutal produce
effects in ten to 15 minutes, but their duration is only two to four hours. Maurer & Vogel,
supra note 29, at 106.
108. Dependence is used in this article to include both physical dependence and psycho-
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drugs. A 1940 study revealed that barbiturate addiction accounted for
more than ten percent of all non-alcohol addiction cases reported by thir-
teen hospitals.'0 9 Interestingly, however, none of these addicts showed
any withdrawal symptoms."10 In his famous 1950 study, Dr. Harris Isbell
confirmed the findings of the earlier study, concluding that barbiturate
intoxication did represent a real physical dependence."' Isbell, however,
did uncover barbiturate withdrawal symptoms-symptoms so severe, he
argued, that barbiturate withdrawal was in fact more dangerous than
opiate withdrawal." 2 In cases of barbiturate withdrawal, severe convul-
sions may occur; whereas, in opiate withdrawal, convulsions or lack of
muscle control have not been observed." 3 The convulsions in barbiturate
withdrawal have been known to block respiration, thereby causing
death." 4 There is one definite similarity, however, between opiate and
barbiturate withdrawal. Both have been observed in infants born to
mothers who used either type of drug during the last trimester of preg-
nancy. 31
The speed with which barbiturate dependence (either physical or psy-
chological) can occur is a matter of debate. Most scientists agree, how-
ever, that it will occur more rapidly than alcoholism. Studies show that
alcoholism can take from three to fifteen years to become chronic."'
There is evidence that many people who are kept deeply intoxicated for
long periods of time can become dependent on depressants in as little as
ten to twelve days."' Some would claim that a barbiturate habituW can be
created after only ten doses."" Isbell himself reported that if the daily
logical dependence. In 1964, the World Health Organization recommended using the term
"drug dependence" to replace two earlier terms, "drug addiction" and "drug habituation."
See Eddy, Halbach, Isbell & Seevers, Drug Dependence: its Significance and Characteristics,
32 WHO Bull. 721, 722 (1965). For definitions of these terms, see McLaughlin, supra note
69, at 552-54.
109. Hearings on Control of Narcotics, Marihuana and Barbiturates Before a Subcomm.
of the House Comm. on Ways and Means, 82d Cong., 1st Sess. 33 (1951).
110. Id.
111. BNDD Report 121.
112. Id. at 122-23.
113. R. Horman & A. Fox, Introduction to Drug Awareness 30-31 (R. Horman & A. Fox
eds. 1970).
114. BNDD Report 122.
115. Id. at 123.
116. Soden, The Need for Realistic Treatment of Alcohol and Drug Addiction, Fed. Pro-
bation, Mar. 1973, at 40.
117. Subcomm. Hearings, supra note 13, at 1222.
118. California Hearing, supra note 79, at 85 (testimony of Dr. Andy Peoples). Of course,
any such estimates cannot take account of individual susceptibilities to a particular drug or
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dose of barbiturate approaches 800 to 900 milligrams for as long as sixty
days, withdrawal will occur upon removal of the drug."'
As for the major tranquilizers, they may be unique in their relatively
low potential for causing dependence. Large amounts of these tranquil-
izers will lead neither to coma nor to physical or psychic dependence." 0
Minor tranquilizers, however, will cause dependence if taken in large
enough doses over a prolonged period of time. For example, Librium will
produce dependence if 300 to 600 milligrams (about ten times the recom-
mended dose) are taken over a five-month period."2 Once dependence on
a minor tranquilizer occurs, it is no less consuming than barbiturate de-
pendence.122 Various studies have demonstrated that methaqualone abuse
also leads to dependence.' A dosage of 1.2 grams of methaqualone a day
has been reported to lead to dependence. 24 In a recent report, the Bureau
of Narcotics and Dangerous Drugs concluded that "methaqualone pro-
duces a severe physical dependence characteristic of the barbiturate-
alcohol type."'125
4. Toxicity, Accidental Death, and Suicide
The toxicity of an overdose of barbiturates was confirmed as far back
as 1903-the year in which Veronal, the first barbiturate, was intro-
duced.126 For those bent on suicide, barbiturates offer an agreeable way
to ensure a peaceful end.'27 Although it is usually claimed that a lethal
dose of barbiturates is fifteen times the sleep-inducing dose,'128 this ratio
does not hold true if the barbiturates are intravenously injected. In that
case a lesser dose of the drug can kill, usually within a matter of
minutes.2 9
to drug-taking in general. Individuals with addiction-prone personalities become dependent
more quickly and totally than others.
119. BNDD Report 122-23.
120. Lingemen, supra note 21, at 141.
121. Id. at 126-27.
122. See National Clearinghouse for Drug Abuse Information, supra note 62, at 5-6.
123. Ognibene, There's Gold in Them There Pills, 168 New Republic, Apr. 21, 1973, at 14.
124. Id.
125. BNDD Methaqualone Report 54.
126. See note 42 supra and accompanying text.
127. As with hemlock among the ancient Greeks, the relative ease and painlessness of
using sleeping pills may actually contribute to the suicide rate. See Daube, The Linguistics
of Suicide, 1 Phil. &Pub. Aff. 387, 393 (1972).
128. BNDD Report 115.
129. Id. Some mention should be made of the various methods of taking sedatives. The
most common form is swallowing sedatives in tablet or capsule form-in street parlance,
this method is called dropping or popping pills. Intravenous injection, or shooting, of seda-
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In addition to suicide, there are many accidental deaths attributed to
barbiturates. These accidental deaths can occur in either of two ways.
First, as with other drugs, individuals can have idiosyncratic or allergic
reactions to barbiturates. 130 Although these abnormal reactions usually
take the form of skin rashes or other forms of dermal eruption,' 8' they
could be fatal if severe enough. The second form of accidental death,
however, is far more common. It is caused not by an allergic reaction but
rather by individual misjudgment. In order to fall asleep, an individual
may take a strong dose of barbiturate sleeping pills. After a brief interval
of sleep, he may awake and think he has forgotten to take his pills. The
first barbiturates may have made the individual confused or drowsy. In
this state he may mistakenly take a further dose which combined with
the first can be fatal. 32 Statistics confirm that deaths from barbiturates
are a serious national problem. Between 1967 and 1971, Philadelphia and
Pittsburgh reported 115 and 118 barbiturate deaths respectively.88 Of
the 569 reported drug deaths in Los Angeles in the first half of 1972,
309 resulted from barbiturates. 34
Both tranquilizers and methaqualone can be fatal if taken in exces-
sively large doses. Substantially fewer suicides and accidental deaths,
however, have been attributed to tranquilizers than to the barbiturates.'
As for methaqualone, it has been blamed for at least 313 overdose poison-
ings and 53 suicides during one recent sixteen-month period.8 0
tives does take place. Often the powder is mixed not only with water but also with other
drug substances to obtain the injectable solution. Injection of barbiturates may be more
prevalent in Europe than in the United States. See N. Bejerot, Addiction and Society 43
(1970), wherein the author states that hundreds of Swedish addicts inject Nembutal regu-
larly. Bejerot also reports an increase in barbiturate injection in England. Id. Injecting bar-
biturates is a dangerous occupation. Injecting any substance can lead to abscesses or, if an
artery is struck, to gangrene. Some addicts may require amputations. Ognibene, Legal Drugs,
Illegal Abuse-Amphetamines and Barbiturates, 168 New Republic, Feb. 3, 1973, at 21, 23.
130. See generally BNDD Report 117.
131. Grolman, supra note 16, at 166.
132. See California Hearing, supra note 79, at 86 (testimony of Dr. Andy Peoples). One
early medical report suggested that sugar injections could be beneficial in barbital poison-
ings. It is important that the kidneys eliminate the toxic doses in the bodily system. Sugar
solutions increase the rate of urine secretion. 102 Am. J. Pharm. 599 (1930). Naloxone, a
specific narcotic antagonist, seems to have little effect in cases of sedative poisonings. The
Lancet, Mar. 3, 1973, at 452.
133. 74 U.S. News & World Rep., Apr. 23, 1973, at 59.
134. Id. See generally BNDD Report 149-52.
135. Rosenthal, Dangerous Drug Legislation in the United States: Recommendations and
Comments, 45 Texas L. Rev. 1037, 1044 (1967).
136. 74 U.S. News & World Rep., Apr. 23, 1973, at 60. Methaqualone poses additional
problems for the user. Because it is metabolized in the liver, methaqualone is not recom-
mended for individuals with liver ailments. Sedam & Tice, supra note 84, at 64.
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5. Multi-Drug Abuse
Barbiturates are frequently taken in combination with various other
abused drugs, such as alcohol, heroin and stimulants. 131
Barbiturates have been called solid alcohol and alcohol, liquid bar-
biturates.138 Both produce a similar intoxication and enhance the effects
of the other. 39 If a person were to have a drink and then take a barbitu-
rate, the effects of the two added together would increase the chance of a
possible overdose. Death has been reported with as little as 300 milli-
grams of a short-acting barbiturate and a few ounces of alcohol.1 0 With
an estimated nine million alcoholics in the United States,1"' the potential
danger of widespread alcohol-barbiturate abuse is serious.'
Since both heroin and barbiturates are "down" drugs, barbiturates are
commonly used either as an alternative to, 43 or an adulterant for,
heroin'44-particularly during times of heroin scarcity. As does alcohol,
barbiturates heighten the effects of heroin; thus when taken with bar-
biturates, a small amount of heroin will produce a more powerful effect.
Interestingly, barbiturates have also been used to ease withdrawal from
heroin.145
If two similar drugs such as barbiturates and heroin increase the effects
of the other, dissimilar drugs such as barbiturates and amphetamines have
an opposite effect. Thus, a woman may take a barbiturate in the evening
to go to sleep and an amphetamine in the morning to wake up and dispel
137. Multi- or poly-drug abuse is a growing phenomenon in the United States--perhaps
it now represents the rle, rather than the exception. Wald & Hutt, The Drug Abuse Survey
Project: Summary of Findings, Conclusions, and Recommendation, in Dealing with Drug
Abuse: A Report to the Ford Foundation 3, 5 (1972).
138. E. Brecher, supra note 94, at 252.
139. The increased effect occurs because barbiturates hinder the breakdown of alcohol
in the body. 83 Time, Jan. 3, 1964, at 48.
140. Ognibene, Legal Drugs, Illegal Abuse-Amphetamines and Barbiturates, 168 New
Republic, Feb. 3, 1973, at 21, 23.
141. Soden, The Need for Realistic Treatment of Alcohol and Drug Addiction, Fed. Pro-
bation, Mar. 1973, at 40.
142. A study in Dade County, Florida, shows that of 132 persons who died from barbi-
turate-related causes during 1970 and 1971 and were tested for the presence of alcohol, 35
percent tested positive. National Commission-Second Report 194. In fact, it has been said
that a pure alcohol problem is a phemonenon of the over-So age group. Alcoholism com-
pounded, 94 Sci. News 338 (1968).
143. National Commission-Second Report 145.
144. The Analysis of Heroin, 5 U.N. Bull. Narc., Apr.-June 1953, at 27, 28. An adult-
erant potentiates the effects of other drugs; a dilutent merely dilutes the strength of other
drugs. Id.
145. BNDD Report 131. Barbiturates, like cocaine, are also being abused by methadone
maintenance patients. Id.; McLaughlin, supra note 69, at 555-56.
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any barbiturate hangover. A youthful drug abuser, on the other hand,
may inject a speedball-a combination of a depressant and a stimulant-
to "go fast slow." 48
Multiple drug abuse in its various forms poses difficult problems for
the physician who must detoxify an addict. To cite but one example:
multiple drug use can and often does result in multiple addictions. How-
ever withdrawal from each of these addictions does not take place simul-
taneously; rather it may be spaced over a period of time. For example,
withdrawal from alcohol usually begins about twelve hours after the last
drink, and may continue for as long as four days. 147 In contrast, barbitu-
rate withdrawal doesn't commence until about four days after the drug
is removed. 4 ' Finally, the withdrawal from tranquilizers doesn't occur for
seven or more days. 49 With this staggered pattern of withdrawals, an
addict with multiple addictions could be inadvertently discharged between
the end of alcohol withdrawal and the first signs of barbiturate or tran-
quilizer withdrawal. In some situations, this could be a fatal mistake. The
convulsions that may accompany barbiturate withdrawal usually require
trained medical supervision.'"0
C. Special Problems Associated With Sedative Abuse
1. Ready Availability
As has already been mentioned, 15' the production of barbiturates in the
United States approximates 1,000,000 pounds a year. The legitimate pro-
duction supplies not only the legal market but also, indirectly, the illegal
market. The ways. in which legally produced drugs are diverted into
illegal channels are, of course, many and varied.
Sedatives can be pilfered from drug manufacturers, distributors, re-
tailers, physicians and sometimes even patients. For the year ending April
1, 1972, the Bureau of Narcotics and Dangerous Drugs reported over
146. A speedball is usually a mixture of heroin and cocaine, but there is no reason why
barbiturates cannot serve in place of the heroin. Lingeman, supra note 21, at 226.
147. Alcoholism compounded, 94 Sci. News 338, 339 (1968).
148. Id.
149. Id.
150. In addition to the convulsions, the addict will run a high fever-perhaps as high
as 104'F. Cold packs, however, are contraindicated because they would strain the already
impaired respiratory system. The Problem of Barbiturates in the United States of America,
9 U.N. Bull. Narc., Apr.-June 1957, at 15, 17. During the early stages of withdrawal, a bed
with sideboards should be provided so that if the convulsions are strong, the addict will not
roll out of bed. Id. After withdrawal, it usually takes the body several months to normalize.
Amphetamines and Barbiturates, The Up and Down Drugs, 58 Today's Educ., Mar. 1969, at
42, 44.
151. See note 11 supra and accompanying text.
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seven million stolen barbiturate doses.5 2 There are no available statistics
on the amount of tranquilizers stolen.
Doctors' prescriptions are another source of illegal drug diversion.
There will always be unethical physicians ("script doctors") who will
write unnecessary prescriptions after giving cursory "physical examina-
tions" to clear their records.153 Even honest doctors may inadvertently
contribute to illegal diversion by overprescribing. The fact of widespread
medical overprescription has been amply documented.'
Unauthorized sales by retail distributors is a third major source of
illegally diverted drugs. Although forged prescriptions do account for a
portion of these unauthorized retail sales, the vast majority are directly
traceable to the drug retailers themselves. For the period ending Decem-
ber 31, 1962, 78 percent of the convictions for illegal sale of either am-
phetamines or barbiturates involved retail drug firms, pharmacists or
their employees.' 55
Although sedatives are illegally imported into the United States, the
ordinary pattern of smuggling depressants tends to be quite different
from that of heroin or cocaine. There are recent indications, however,
that the old patterns of barbiturate smuggling are changing. The time-
honored method was to export barbiturates to Mexico and then to smug-
gle them back into the United States.' The individual or firm in Mexico
to which the drugs were exported was usually non-existent. One investi-
gation showed that of forty-five stores in Mexico consigned restricted
drugs, only five were legitimate.'57 More recently, however, some of the
barbiturates smuggled into the United States have not been of American
origin, indicating foreign suppliers are entering the domestic illegal seda-
tive market.5 8
Interestingly, clandestine production does not seem to be a significant
source of street depressants.50 Diversion from legal distribution channels
seems sufficient to fill the present requirements of the illegal market. If
clandestine production is negligible, it would seem that the way to dry up
152. BNDD Report 160.
153. California Hearing, supra note 79, at 46.
154. BNDD Report 165-69.
155. The President's Advisory Comm'n on Narcotic and Drug Abuse, Final Report 44-45
(1963). See also N.Y. Times, Aug. 16, 1973, at 19, col. 1.
156. The President's Advisory Comm'n en Narcotic and Drug Abuse, Final Report 47
(1963).
157. California Hearing, supra note 79, at 59.
158. The President's Advisory Comm'n on Narcotic and Drug Abuse, Final Report 47-48
(1963).
159. Some clandestine production of depressants, however, is beginning to appear. In-
gersoll, supra note 2, at 22.
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the market for illegal depressants is to stop the leakage from legal distri-
bution channels. The problem, however, is to find a means of stopping
this leakage. Medical need for depressants is widespread. It has been esti-
mated that if the medical requirements for amphetamines can be counted
in the thousands of doses, barbiturate requirements must be counted in
the billions of doses.16 Thus, there is no realistic way to reduce produc-
tion to any significant extent. Although rigid production and distribution
controls' 6 ' are part of the answer, past history would seem to indicate that
at the various levels of a drug distribution system leakage is inevitable.
2. Low Cost
In addition to their ready availability, a prime reason for the popu-
larity of depressants in the drug subculture is their low cost. In many
instances, the barbiturate user can acquire his supply of drugs legiti-
mately from a doctor's prescription. 62 Even if the user were forced to
buy from a pusher, he could probably buy one hundred Seconal tablets
for between five dollars and eight dollars.' There have been reports
that certain pills sell for as little as twenty-five cents each,10 4 although
the price of others may be as high as seventy-five cents each.,0 , Since
two pills a day can produce euphoria in teenagers,0 6 it is easy to see bow
a barbiturate high is within the financial reach of the average teenager,
and, a fortiori, of the average adult drug user. Their comparatively low
cost clearly differentiates depressants from other abused drugs and ren-
ders their widespread abuse almost inevitable.
3. Depressants as Criminogens
Until quite recently there were few studies made of the connection
between drugs and crime. Whatever studies there were attempted to show
that drug abuse and crime were highly correlated. 67 These studies clearly
demonstrated that drug users did commit crimes-but mainly drug re-
lated crimes, such as possession or sale of narcotics. These studies, how-
160. Ognibene, Legal Drugs, Illegal Abuse-Amphetamines and Barbiturates, 168 New
Republic, Feb. 3, 1973, at 21, 22.
161. This method was quite successful in controlling amphetamines. Id. 21-22.
162. Subcomm. Hearings, supra note 13, at 83.
163. Id. at 85.
164. Id. at 89.
165. Id. at 85. There are three methods of taking depressants. The first and most common
method is to take the pills orally. The contents of the pills can be snorted like cocaine or
injected intravenously like heroin. See generally id. at 83; note 129 supra.
166. See Subcomm. Hearings 88.
167. For a review of early research on the relationship between drug usage and crim-
inal behavior, see U.S. Dep't of justice, Bureau of Narcotics & Dangerous Drugs, Drug Usage
and Arrest Charges 8-18 (1971).
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ever, made no effort to compare non-drug related crime statistics in drug
user and non-drug user populations. In 1971, however, the Bureau of
Narcotics and Dangerous Drugs published a report analyzing drug usage
and arrest charges in six cities throughout the United States."'8 The sta-
tistics concerning the interconnection of barbiturate use and crime are
quite revealing.16 9
When compared to non-drug users, those who use barbiturates had a
smaller percentage of arrest charges for aggravated assault: 16.1 percent
of the non-drug users had been charged with aggravated assault as against
only 8.3 percent of the barbiturate users. Non-drug users also had a
higher percentage of arrest charges for criminal homicide and forcible
rape. The barbiturate users, however, had a significantly higher per-
centage of burglary and robbery arrest charges than non-drug users.
These statistics would seem to indicate that non-drug users are at least
charged more often with violent crimes than barbiturate users. The bar-
biturate users, on the other hand, are more frequently charged with
acquisitive crimes.
When barbiturate users are compared to users of other drugs, bar-
biturate users are charged with aggravated assault more than twice as
often as heroin and cocaine users, and almost twice as often as amphet-
amine users. As for criminal homicide and forcible rape, the arrest charge
statistics for barbiturate users are higher than for heroin users, about
the same as for cocaine users and less than those for amphetamine users.
Burglary and robbery statistics are approximately the same for all drugs
mentioned. These figures seem to indicate that among drug users, bar-
biturate users tend to be more frequently charged with crimes of violence
(aggravated assault, criminal homicide and forcible rape) than users
of other drugs.
This conclusion, that the barbiturate user is more violence-prone than
other drug users, seems to be confirmed in the drug subculture itself.
The barbiturate user has been called "'worse than the meanest fighting
drunks.' "17 One barbiturate user described taking his drug in this way:
"They always make me hate and mean or something, those reds and yel-
low jackets. Drink a little bit behind it like I said and a person can look
at you, just glance at you and you poke 'em off in their nose .... "I'll
The irony of the situation is evident: depressants which should tran-
quilize and calm can in fact galvanize and inflame.
168. Id.
169. Id. at 173, 175. The subsequent statistics can be found on various charts contained
on these pages.
170. 74 U.S. News & World Rep., Apr. 23, 1973, at 60 (quoting an unnamed California
prosecutor).
171. See H. Blumer, supra note 94, at 21.
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II. LEGISLATIVE CONTROLS
Although narcotic drugs such as morphine and cocaine began to be
regulated by the states as early as the 1870s,172 depressants did not come
under state regulation until over fifty years later. Even when depressants
were finally regulated, the law tended to categorize them differently
from the narcotic drugs, 73 reflecting an attitude that the depressants were
in fact less harmful than other abused drugs. The reasons why this atti-
tude developed are not difficult to discern. First, whereas depressants
have many legitimate medical uses, most narcotic drugs do not. For ex-
ample, although heroin did briefly appear in the official phlarmacopoeia
of American drugs in 1910,171 it has not been widely used as a medicine
in this country for over sixty years. Even cocaine (which can be and still
is used in eye and dental surgery) has largely been replaced by other
drugs such as novocaine and procaine. 75 Second, unlike the narcotic
drugs which have become associated in the public mind with prostitutes,
criminals and other undesirable elements, depressants have been widely
used as sedatives at all levels of the socioeconomic ladder. Hence, no
stigma has attached to their use. Third, and perhaps most important,
the dangers of depressant use were not fully realized until quite recently.
It was not until the 1950s that barbiturates were conclusively proven to
be addictive. 7 '
An analysis of state and federal legislation regulating depressants will
demonstrate clearly that public awareness of the dangers of depressant
abuse was late in coming. Even as the evidence of their danger mounted,
there was a reluctance on the part of the legislators to punish the abuse
of depressants as harshly as the abuse of narcotics.
A. Early State and Federal Legislation Regulating Depressants
1. State Legislation to 1970
Although there was some earlier legislation regulating the use of
chloral hydrate, 17 7 the first state to place specific controls over the more
modern categories of depressants, such as the barbiturates, was Califor-
172. See, e.g., Act of Feb. 9, 1877, ch. 27, §§ 1-5, [18771 Nev. Laws 69.
173. Narcotic drugs have been variously defined. Medically speaking, a narcotic drug Is
one that depresses the central nervous system, producing stupor or sleep. In this sense a
depressant might be considered a narcotic drug. From the legal standpoint, however, nar-
cotics have been defined as basically two categories of drugs-opium and its derivatives
(morphine and heroin) and cocaine. Cocaine, of course, is a stimulant and would not be
considered a narcotic drug under medical terminology.
174. Heroin in the Official Pharmacopoeia, 5 U.N. Bull. Narc., Apr.-June 1953, at 19.
175. See generally McLaughlin, supra note 69, at 544-47.
176. See notes 111-19 supra and accompanying text.
177. See, e.g., Act of Apr. 25, 1900, ch. 667, § 198, [1900] Laws of N.Y. 1471, 1480-81.
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nia. In 1929,178 the California Legislature made it "unlawful for any per-
son to sell, furnish, or give away, or offer to sell, furnish, or give
away any veronal, barbital or any of its salts, derivatives, or com-
pounds of the foregoing substance ...except upon the written order
or prescription of a physician ....,"' Violations of the act were mis-
demeanors punishable by a fine not exceeding $200 or by imprisonment
not exceeding six months or both. The California statute, however, did
not criminalize the illegal possession of veronal or barbital. One year
later in 1930, Virginia enacted legislation"'0 requiring that sales of "hyp-
notic drugs" including barbital could be made only upon prescrip-
tion. Like California, the Virginia enactment criminalized only the non-
prescription sale, but not the possession, of these drugs. Other states
began to follow California's and Virginia's lead. In 1933, for example,
New Jersey,' 8 ' Maine 8 2 and Oklahoma' 3 adopted special laws to regu-
late barbiturates. By 1946, thirty-six states had either laws or regulations
in force which directly or indirectly controlled the distribution of either
barbiturates alone or barbiturates and other "hypnotic drugs.", Some
of this later legislation, however, differed in several respects from the
early California legislation. For example, a New York statute adopted
in 1946 outlawed not only the non-prescription sale or dispensation of
any barbiturate or any "other hypnotic or somnifacient drug,"'88 but their
illegal possession as well.188 In addition the New York statute increased
the severity of applicable penalties for violations of the Act. Anyone con-
victed of an offense was liable to either imprisonment for up to one year,
a fine of not more than $500, or both.
The end of World War II marked a turning point in the American
social and legislative attitude toward depressants. The war had disrupted
traditional opium and heroin supply routes, forcing narcotic addicts to
search for new drugs either to substitute for heroin or to adulterate the
little heroin that was available. 7 Some of these addicts began to use
barbiturates because barbiturates could enhance the effects of weak
178. Act of May 24, 1929, ch. 449, [1929] Cal. Laws 812.
179. Id.
180. Act of Mar. 20, 1930, ch. 164, [1930] Va. Acts 445.
181. Act of June 21, 1933, ch. 279, [1933] N.J. Laws 749.
182. Act of Mar. 28, 1933, ch. 204, [1933] Me. Laws 347.
183. Act of Apr. 24, 1933, ch. 77, [1933] Okla. Laws 140.
184. Hearings on Control of Narcotics, Marihuana and Barbiturates Before a Subcomm.
of the House Comm. on Ways and Means, 82d Cong., 1st Sess. 14 (1951).
185. Act of Apr. 8*, 1946, ch. 597, § 1, [1946] Laws of N.Y. 1246. Hypnotic or somnifa-
dent drugs would obviously include such nonbarbiturates as chloral hydrate and paral-
dehyde among others.
186. Id. § 3.
187. For a discussion of the war's effect on the "cutting" or adulterating of heroin se
A. McCoy, The Politics of Heroin in Southeast Asia 5-6 (1972).
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heroin. 188 As concern about barbiturate abuse began to spread, there was
a simultaneous outbreak of amphetamine abuse in various parts of the
world-particularly in Japan. 8 Thus, the public, which had long been
aware of the dangers of narcotic abuse, was now exposed to the poten-
tial dangers inherent in the abuse of two new categories of drugs-
"uppers" (the amphetamines) and "downers" (the barbiturates and other
depressants).
As concern over depressant abuse grew, attempts were made to unify
state legislation regulating their distribution. In 1955 the Council of
State Governments proposed to the states "An Act to regulate the han-
dling, sale and distribution of hypnotic or somnifacient drugs."'00 In
the explanatory statement preceding the Act, the drafters remarked:
The proposal is recommended for consideration of states which may require new
legislation in this field, or which may wish to broaden or strengthen the coverage of
existing legislation. The attention of states which have comparable laws confined to
control of barbiturates is called specifically to the wider coverage of this proposal.',
The proposed legislation outlawed the illegal sale and possession of
barbiturates and other hypnotic or somnifacient drugs. 2 In this respect
it was quite similar to the 1946 New York act in that it covered not only
barbiturates but other depressant drugs as well, and prohibited both
their illegal possession and sale. The model act, however, did contain
certain new features-features which had long been part of federal and
state narcotic control laws but had not been used uniformly in laws
regulating depressants. The Act required those in the business of dis-
tributing depressant drugs to "make a complete record of all stocks of
drugs on hand on the effective date of this act" and to "maintain detailed
records and inventories relating to drugs manufactured, purchased, sold,
distributed and handled ... ."I" The responsibility for keeping records
was not just imposed upon retail pharmacists but also upon drug manu-
facturers and wholesalers. 94 The Act represented an attempt to control
depressants not only at the point of retail distribution but also at the
point of manufacture. As penalties for violations of the Act, the drafters
188. See notes 143-45 supra and accompanying text.
189. For reference to the post-war amphetamine problem in Japan see Nagahama, A
review of drug abuse and counter measures in Japan since World War 11, 20 U.N. Bull.
Narc., July-Sept. 1968, at 19.
190. The Council of State Governments, Suggested State Legislation: Program for 1955,
at 28-32.
191. Id. at 28.
192. Id. at 28-29, § 1(1).
193. Id. at31, § 4(1)(A), (B).
194. Id. § 4(1).
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suggested a fine not exceeding $1,000 or imprisonment for not more than
one year, or both."0 5
The Council of State Governments proposed yet another model act
in 1966. Recognizing the continued indiscriminate use of "pep pills" and
"goof balls," 190 the Council drafted the Depressant and Stimulant Drug
Control Act which established similar controls for both amphetamines
and barbiturates.1 97 Recognizing that it was difficult to name each drug
to be covered by the Act "and that new drugs of similar nature come on
the market frequently,"198 the drafters suggested certain criteria for a
drug to be included under the Act's coverage and then empowered state
boards of health to determine which specific drugs met the criteria.1"'
Thus the term "drug" for purposes of the act was defined to mean
any drug containing any quantity of a substance which significantly affects or alters
consciousness, the ability to think, critical judgment, motivation, mood, psychomotor
coordination or sensory perception and is substantially involved in drug abuse or has
substantial potential for such involvement.2 00
The Act continued existing prohibitions on illegal sale and distribution of
depressants but made certain modifications in the prohibitions on pos-
session of depressants. Where the 1955 Act had prohibited possession of
these drugs except upon the prescription of a practitioner or upon his
good faith delivery in the course of his professional practice,20 1 the 1966
proposed statute made possession illegal when it was "other than for (1)
the personal use of [a person] or a member of his household, or (2) for
administration to an animal owned by him or a member of his house-
hold. 202 Thus, technically it could be possible for a person to possess
depressants legally even though he himself had not received a prescrip-
tion for them.
Although the proposed statutes of the Council of State Governments
did influence the legislation of many states, there continued to be a wide
diversity of state legislation regulating depressants during the 1960s.203
On one point, however, most state legislation tended to agree. Depres-
sants were still treated in a totally different fashion from narcotic drugs,
195. Id. § 7.
196. The Council of State Governments, Suggested State Legislation 1966, at 202.
197. Id. at 202-04.
198. Id. at 202.
199. Id.
200. Id. at 203, § 2(a).
201. The Council of State Governments, Suggested State Legislation: Program for 1935,
at 30, § 2 (5).
202. The Council of State Governments, Suggested State Legislation 1966, at 203, § 3.
203. See Rosenthal, Dangerous Drug Legislation in the United States: Recommendations
and Comments, 45 Texas L. Rev. 1037, 1063 (1967).
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both in terms of the extent of their regulation and in terms of the penal-
ties imposed for violation of the law. At the same time, however, there
was a mounting body of opinion that the abuse of depressants, par-
ticularly barbiturates, was as serious a threat to a person's health as the
abuse of heroin and other narcotic drugs..2 4 This growing scientific evi-
dence was the catalyst for federal intervention into the problem of de-
pressant abuse.
2. Federal Legislation to 1970
The first significant federal regulation of depressants did not occur
until 1965,205 more than fifty years after the passage of the Harrison
Act which had brought narcotic drugs under federal control.20 To be
sure, there had been some minimal federal legislation prior to 1965 that
could be considered as regulating the use of depressants. For example,
the Federal Food, Drug and Cosmetic Act of 1938 prohibited the intro-
duction and receipt in interstate commerce of any drug that was mis-
branded.201 A drug was considered misbranded if it was for use by man
and contained any quantity of barbituric acid, chloral and paraldehyde
and did not bear a label containing (a) the name, quantity and per-
centage of the substance and (b) the statement "Warning-May be habit
forming."2°s If these drugs were dispensed pursuant to a doctor's pre-
scription, however, there was no requirement that the label or warning
be affixed as long as the prescription was marked as nonrefillable, con-
tained the name of the doctor, the date of the prescription and the name
and place of business of the dispenser."0 Violations of the Act were pun-
ishable by imprisonment for up to one year, a fine of not more than
$1,000, or both. l0 In 1951, the Federal Food, Drug and Cosmetic Act
was amended to require that all habit-forming drugs (barbiturates in-
cluded) be dispensed only upon the prescription of a doctor.211 In 1962,
the Act was further amended to require all manufacturers and processors
of drugs (including manufacturers and processors of depressants) to
204. Id. at 1043-44.
205. Drug Abuse Control Amendments of 1965, Act of July 15, 1965, Pub. L. No. 89-74,
79 Stat. 226 (codified at 21 U.S.C. §§ 321, 331, 333, 334, 352n, 360, 360a, 372 (Supp. 1I
1973)).
206. Act of Dec. 17, 1914, ch. 1, §§ 1-12, 38 Stat. 785.
207. Act of June 25, 1938, ch. 675, § 301(b), 52 Stat. 1042 (codified at 21 U.S.C. § 331(b)
(1970)).
208. Id., §502(d), 52 Stat. 1050 (codified at 21 U.S.C. § 352(d) (1970)).
209. Id. § 503(b), 52 Stat. 1052 (codified at 21 U.S.C. § 353 (1970)).
210. Id., § 303(a), 52 Stat. 1043 (codified at 21 U.S.C. § 333(a) (1970)).
211. Act of Oct. 26, 1951, ch. 578, § 1, 65 Stat. 648 (codified at 21 U.S.C. § 353(b) (1970)).
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register with the Food and Drug Administration.2 12 At this time, how-
ever, manufacturers or processors of drugs were not required specifically
to include in their registration statements the fact that they produced
depressants.
The 1965 amendments to the Federal Food, Drug and Cosmetic Act,
however, were intended as a comprehensive plan to regulate the produc-
tion and distribution of both stimulant and depressant drugs. With re-
spect to depressants, the amendments prohibited the manufacture of all
barbiturates and other drugs which the Secretary of Health, Education
and Welfare designated as having a potential for abuse because of their
depressant effect on the central nervous system.213 Excepted from this
prohibition were registered drug manufacturers who produced drugs for
use in research, teaching, medicine or for chemical analysis..214 If a drug
manufacturer wished to produce depressants, the amendments mandated
that his registration statement refer specifically to his manufacturing of
depressants. 15 In addition to this registration requirement, manufac-
turers were also required (1) to prepare an initial inventory of each
depressant on hand when the amendments took effect and (2) to main-
tain future records of all such manufacturing.2 10
Sales of depressants were also regulated by the 1965 amendments. All
sales were forbidden except by those who were legally in the chain of
drug distribution and then only in the ordinary and authorized course
of their business. 2 7 Wholesale distributors of these drugs were required
to register, although retail pharmacies, clinics, hospitals or dispensing
physicians were exempted from registration.2 18 Of course, prescriptions
were still required in order to dispense barbiturates legally. Possession
of depressants was made a crime unless it was for the personal use of the
possessor or a member of his household or for administration to an animal
owned by him or by a member of his household.210 In 1968, unauthorized
possession of depressants-even for personal use-was criminalized. - °
212. Drug Amendments of 1962, Act of Oct. 10, 1962, Pub. L. No. 87-781, § 302, 76
Stat. 794 (codified at 21 U.S.C. § 360 (1970)).
213. Drug Abuse Control Amendments of 1965, Act of July 15, 1965, Pub. L. No. 89-74,
§ 3(a), 79 Stat. 227.
214. Id.§ 3 (b).
215. Id. § 4, 79 Stat. 231.
216. Id. § 3(b), 79 Stat. 229.
217. Id. § 3(b), 79 Stat. 228-29.
218. Id. § 3(b), 79 Stat. 228.
219. Id. § 3(b), 79 Stat. 229; cf. text accompanying note 202 supra.
220. Act of Oct. 4, 1968, Pub. L. No. 90-639, § 2(2), 82 Stat. 1361, amending 21 U.S.C.
§ 360a (c) (Supp. MI 1968).
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It was Congress' hope that these amendments to the Federal Food,
Drug and Cosmetic Act would serve to check the growing abuse of de-
pressants and stimulants. But a close reading of the amendments shows
that Congress did not in fact consider the abuse of depressants or stimu-
lants to be as dangerous a threat to the nation as the abuse of narcotic
drugs. For example, Congress did not impose production quotas on man-
ufacturers of depressants as it had on manufacturers of narcotic drugs
five years earlier.2 21 The result of not imposing production quotas was
that an unlimited amount of these drugs could be produced legitimately
by registered manufacturers. Of course, the possibilities for illegal diver-
sion increased in direct proportion to the amount of drugs manufactured.
In addition, Congress did not impose the same harsh penalties on those
who violated the 1965 amendments as it did on those who violated com-
parable narcotics legislation. 22 Even enforcement of the 1965 amend-
ments was initially entrusted to the Food and Drug Administration in
the Department of Health, Education and Welfare, rather than to the
Bureau of Narcotics in the Treasury Department, the agency which had
enforced narcotics legislation for many years.28 Although all drug en-
forcement, including depressant enforcement, ultimately was switched
to the Department of Justice in 1968,11 its initial assignment to the Food
and Drug Administration seems to indicate that at least in 1965 Congress
viewed depressant abuse more as a national health problem than as a
criminal law problem.
B. Present Federal Legislation Regulating Depressants
The passage of Title II of the Comprehensive Drug Abuse Prevention
and Control Act of 197025 ended the separate treatment of depressant
and narcotic drugs. This enactment combined the regulation of all so-
called controlled substances (narcotics, depressants and stimulants) in
one statute.
221. Act of Apr. 22, 1960, Pub. L. No. 86-429, § 7, 74 Stat. 61.
222. Compare, e.g., 21 U.S.C. § 333(a) (1970) ($1,000 and/or one-year imprisonment for
first offenders) with 21 U.S.C. § 960(b) (1) (1970) ($25,000 and/or 1S-years imprisonment
for first offenders).
223. Initially, enforcement of the Harrison Act (see note 206 supra) was entrusted to
the Narcotics Division of the Prohibition Unit of the Internal Revenue Service in the Treas-
ury Department. In 1927, this division became part of the Prohibition Bureau of the
Treasury Department. Act of Mar. 3, 1927, ch. 348, § 1, 44 Stat. 1381. In 1930, the Federal
Bureau of Narcotics in the Treasury Department was finally established. Act of June 14,
1930, ch. 488, § 1, 46 Stat. 585.
224. Reorganization Plan No. 1 of 1968, § 2(a) [printed at 28 U.S.C. § 509 (1970)].
225. Act of Oct. 27, 1970, Pub. L. No. 91-513 §§ 101-709, 84 Stat. 1242 (codified at 21
U.S.C. §§ 801-904 (1970)).
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1. Definition of Controlled Substances
The 1970 Act established five schedules of controlled substances.
Schedule I included substances such as heroin and LSD which have a
high potential for abuse and no current medical value.2-0 While equally
dangerous as the drugs in schedule I, schedule II substances (such as
cocaine and methadone) have a currently accepted medical useY- Ii-
itially, depressants were classified as either schdeule III or schedule IV
controlled substances.228 To be in schedule III, a drug was required
to have a lesser potential for abuse than the drugs in the first two sched-
ules, have a currently accepted medical use in treatment in the United
States, and have a low physical or a high psychological dependence po-
tential. 29 The vast majority of the barbiturates (such as secobarbital
and amobarbital) and glutethimide were placed in this schedule.230 Bar-
bital, chloral hydrate, meprobamate, phenobarbital and paralydehyde
were classified as schedule IV drugs, which meant that they had a low
abuse potential, a currently accepted medical use, and a rather limited
physical or psychological dependence potential." Valium and Librium
were not classified as controlled substances although there were con-
tinuing attempts to bring them under federal regulation.3 2
Although the scientific data linking barbiturate abuse with physical
dependencesa would seem to have dictated that most barbiturates be
included in schedule II, they were not so classified. The significance of
this misclassification becomes apparent when one considers that pro-
duction quotas and other statutory drug control devices are triggered by
a drug's inclusion in schedules I or II. Provision is made in the 1970
Act, however, for the transfer of drugs from one schedule to another.
The Attorney General is given the power under the Act to add to or
transfer between schedules a drug which fits the requirements of a par-
ticular schedule.3 4 Before initiating procedures to control a drug, how-
ever, the Attorney General must request from the Secretary of Health,
Education and Welfare a scientific and medical evaluation of the drug
and his recommendations as to whether the substance should be con-
226. 21 U.S.C. § 812(b) (1), (c) (1970) (schedule I).
227. Id. § 812(b) (2), (c) (schedule II).
228. Id. § 812(b) (3), (4), (c) (schedules III(b)(1), & IV(1), (3), (7), (9), (11)).
229. Id. § 812(b) (3).
230. Id. § 812(c) (schedule 1II(b) (1), (3)).
231. Id. § 812(b)(4), (c) (schedule IV (1), (3), (7), (9), (11)).
232. For example, in Hoffman-La Roche, Inc. v. Kleindienst, 478 Fad I (3d Cir. 1973),
the court held that the procedure used to classify Valium and Librium was illegal.
233. See discussion notes 108-19 supra.
234. 21 U.S.C. § 811 (1970).
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trolled.21 If the Secretary of HEW recommends that a drug not be con-
trolled, the Attorney General does not have the power to control it.
2. Significance of Scheduling
The placement of depressants in schedules III and IV rather than in
schedule II was extremely significant. First, although all drug manufac-
turers must register annually with the Attorney General, manufacturers
of schedule II drugs were additionally subjected to production quotas.230
Since no quotas were imposed on the manufacturers of schedules III and
IV drugs, there was no control over the amount of these substances that
could be manufactured in the United States every year. Second, schedule
II drugs can be dispensed only pursuant to a nonrefillable written pre-
scription, except in emergency situations when an oral prescription suf-
fices.237 Prescriptions for schedules III and IV drugs on the other hand
can be refilled as many as five times within a six-month period from the
date of prescriptions' upon either a written or oral (telephone) prescrip-
tion.230 The less rigid prescription standards make illegal diversion some-
what easier for schedules III and IV drugs than for schedule II drugs.
With a valid prescription, a barbiturate user could easily secure a large
supply of drugs either for his personal use or for further distribution.
Compounding this problem of misclassification is the practice of doc-
tors in overprescribing large quantities of drugs for their patients' use.2"0
Third, the 1970 Act requires that all distributors of schedules I or II
drugs may effect legal transfers only pursuant to a written order from
the person to whom the drugs are to be delivered.24' All such orders must
be made on a special Justice Department form, one copy of which must
be kept by each of the parties to the transaction.242 These special order
forms can only be procured by individuals registered or exempted from
registration under the Act.24 This close scrutiny of each transfer involv-
ing schedules I and II drugs does not exist with respect to drugs in the
other schedules.
A fourth significant result of placing depressants in schedules III and
IV is that the import and export restrictions for non-narcotic substances,
including barbiturates, which are in those schedules are much less strin-
235. Id. § 811(b).
236. Id. § 826(a), (b).
237. Id. § 829(a).
238. Id. § 829(b).
239. Id.
240. For a discussion of the over-prescribing of barbiturates see notes 153-54 supra.
241. 21 U.S.C. § 828(a) (1970).
242. Id. § 828(c) (1), (2).
243. Id. § 828(d) (1).
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gent than for schedules I and II substances or even narcotic substances
in schedules III and IV.2 4 Since there is some evidence that barbiturates
have been legally exported to foreign countries only to be brought back
into the United States,"' there may be need for the tighter restrictions
that apply to schedules I and II drugs. Fifth, the penalties for violating
the 1970 Act often vary depending on whether a schedule I or II, or a
schedule III or IV drug is involved. For example, if a person knowingly
and illegally manufactures heroin or cocaine, schedules I and II drugs
respectively, he can be sentenced to a prison term of up to 15 years, a
fine of up to $25,000, or both.2 40 If the drug were a schedule III sub-
stance, the penalty drops to a prison term of up to 5 years, a fine of up
to $15,000, or both.2 47 In the case of a schedule IV substance, the pen-
alties are lower still-a prison term of up to 3 years, a fine of up to
$10,000, or both.4 8
3. Recent Changes
As the depressant menace increased in scope and intensity during
1972 and 1973, there developed a body of opinion that certain depres-
sants should be transferred to schedule II in order to effect closer control
over their manufacture and distribution. The strategy of transferring
amphetamines from schedule III to schedule II seemed to have had an
important impact on decreasing their availability and consequently their
widespread abuse249 It was argued forcefully that the imposition of
production quotas on barbiturates was necessary for any successful
strategy to limit their abuse.260 The sudden appearance of methaqualone
in the illegal market also resulted in a movement to classify this drug as
a schedule II substance.251 Up to this time, methaqualone had not been
included in any schedule.
The response of the Justice Department came in late 1973. Three com-
monly abused barbiturates-amobarbital, secobarbital and pentobarbital
-were transferred from schedule III to schedule 11,22 and methaqualone
244. Id. §§ 952-53.
245. See discussion at note 156 supra and accompanying text.
246. 21 U.S.C. § 841(b) (1) (A) (1970).
247. Id. § 841(b) (1) (B).
248. Id. § 841(b) (2).
249. The production of amphetamines was cut by 83 percent resulting in a "dying in-
dustry." Reports confirm that amphetamine abuse is on the decline as a consequence of
rigid federal controls. See Ognibene, Legal Drugs, Illegal Abuse-Amphetamines and Barbi-
turates, 168 New Republic, Feb. 3, 1973, at 21-22.
250. But see id. at 22.
251. BNDD Methaqualone Report 70-76.
252. 38 Fed. Reg. 31310 (1973), amending 21 C.F.R. § 130S.12 (1970).
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was also added as a schedule II substance.253 The Drug Enforcement
Administration of the Justice Department lost no time in putting into
effect the changes caused by the reclassification of the three barbiturates.
Interim production quotas, for example, were to take effect on January
1, 1974.254 Moreover, the Drug Enforcement Administration ordered the
monitoring of six other abused barbiturates-cyclobarbital, heptabarbital,
probarbital, talbutal, vinobarbital and butabarbital.2 In addition to
these changes with regard to certain barbiturates and methaqualone, the
Drug Enforcement Administration has taken steps to classify Librium
and Valium as controlled substances,"' although as of this writing these
tranquilizers have not as yet been scheduled.
C. Present State Legislation Regulating Depressants
The passage of the Comprehensive Drug Abuse Prevention and Con-
trol Act of 1970 had a strong impact on the shape of state drug legislation.
Traditionally the states had tended to model their narcotics legislation
on existing federal narcotics legislation. Thus, the 1932 Uniform Narcotic
Drug Act2 57 which had been adopted in most states complemented and
was modelled on the earlier federal Harrison Act. When, in 1970, Con-
gress placed the control of narcotic and non-narcotic drugs under one
statute, the states began to follow suit. The Commissioners on Uniform
State Laws provided the states with the Uniform Controlled Substances
Act.258 The purpose of the new Uniform Act was to "provide an inter-
locking trellis of Federal and State law to enable government at all levels
to control more effectively the drug abuse probem.
2 O
Athough many states have adopted the Uniform Act or some version
of it,260 the remainder of this article will concentrate on the statutory
scheme of but one state-New York. New York has been chosen because
recent amendments to its drug laws have received nationwide attention
and have aroused critical debate.
253. 38 Fed. Reg. 27519 (1973), amending 21 C.F.R. § 1308.12 (1970).
254. Id. at 31311.
255. Id. at 31310.
256. See N.Y. Times, Aug. 16, 1973, at 1, col. 5.
257. National Conf. of Comm'rs on Uniform State Laws, 1932 Handbook 324-38. The
states which did not adopt the uniform act were California and Pennsylvania. National Conf.
of Comm'rs on Uniform State Laws, 1970 Handbook 309.
258. National Conf. of Comm'rs on Uniform State Laws, 1970 Handbook 225-63.
259. Id. at 223.
260. See, e.g., III. Ann. Stat. ch. 56'2, §§ 1100-603 (Smith-Hurd Supp. 1973); Nev. Rev.
Stat. §§ 453.011-.361 (1973); Wash. Rev. Code Ann. § 69.50.101-606 (Spec. Pamphlet 1972),
As of June 30, 1973, 32 states had adopted provisions substantially similar to the Uniform
Controlled Substances Act. See National Conf. of Comm'rs on Uniform State Laws, 1972
Handbook 349.
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1. Controlled Substances
Although the federal and state schedules of controlled substances are
similar, there are certain important differences. While both the New
York and the federal schedules include methaqualone in schedule II,
New York still classifies all barbiturates in schedule III or schedule IV-
even though amphetamines are placed in schedule 11.201 Neither set of
schedules has classified Librium or Valium.
2. Significance of Scheduling
Although certain prescription requirements do hinge on whether a drug
is categorized as a schedule II or a schedules Ill or IV substance,2 1 the
most significant differences between the New York schedules lie in the
area of the criminal law. For the purpose of criminal penalties, New York
divides depressants into two categories; namely, (1) "dangerous depres-
sants" which include methaqualone, the barbiturates and glutethimide
and (2) "depressants" which include chloral hydrate, paraldehyde and
meprobamate.2
a. Possessory Offenses
Under New York law, if a person knowingly and unlawfully possesses
any amount of a controlled substance (including dangerous depressants
and depressants), he is guilty of criminal possession of a controlled sub-
stance in the seventh degree--a class A misdemeanor punishable by up to
one year in jail.2  If the amount of dangerous depressants possessed
exceeds ten ounces or the amount of depressants exceeds two pounds, the
offense escalates to criminal possession of a controlled substance in the
fifth degree-a class C felony, punishable by a possible fifteen-year sen-
tence.2 65 A second conviction for fifth degree criminal possession auto-
matically changes the offense to fourth degree criminal possession-a
class B felony, punishable by a possible prison term of twenty-five
years. 6
6
b. Possession with Intent to Sell
Under the New York Penal Law, possession of any amount of a con-
trolled substance (including dangerous depressants and depressants)
261. See N.Y. Pub. Health Law § 3306 (schedules II, III, IV) (McKinney Supp. 1973).
262. See id. §§ 3330-39.
263. N.Y. Penal Law § 220.00 (12), (13) (McKinney Supp. 1973).
264. Id. § 220.03; N.Y. Penal Law § 70.15 (McKinney 1967).
265. N.Y. Penal Law §§ 70.00(2) (c), 220.09(8), (9) (McKinney Supp. 1973).
266. Id. §§ 220.12, 70.00(2)(b).
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with intent to sell is defined as sixth degree criminal possession-a class
D felony, punishable by up to seven years in jail.2 17
c. Trafficking Offenses
The sale of any amount of a controlled substance is treated as sixth
degree criminal sale-a class D felony under New York law, punishable
by the same penalties as possession of a controlled substance with intent
to sell.268 If the amount sold exceeds ten ounces of a dangerous depres-
sant or two pounds of a depressant, the offense becomes fifth degree crim-
inal sale, a class C felony.26 Just as in the case of criminal possession
of these amounts, a second conviction of fifth degree criminal sale raises
the offense to fourth degree criminal sale, a class B felony. 70
What is particularly interesting in this penalty structure is the com-
parative treatment depressants and stimulants receive. No matter how
large an amount of depressants a first offender sells, he cannot be con-
victed of anything more than a class C felony. This is not the case with
stimulants. For example, a person who is convicted of selling five grams
or more of a stimulant is guilty of second degree criminal sale-a class
A-II felony, punishable by possible life imprisonment as the maximum
sentence.2 ' From this comparison, it appears that the New York Legis-
ature seems to consider stimulants to be a greater criminal threat than
depressants. While stimulants are obviously dangerous and should be
rigidly controlled, they do not lead to physical dependence and possible
death from overdose, as can most depressants. 7  The specter of wide-
spread dependence on barbiturates or other depressants should dictate
penalties at least as severe for their abuse as for stimulant abuse. The
separate treatment of stimulants and depressants under the New York
Penal Law is, therefore, somewhat inexplicable in the light of existing
medical data about the effects of each category of drugs.
III. CONCLUSION
It should be obvious from Part I of this article that depressants are
potentially among the most dangerous of all drugs. Somewhat paradox-
ically, however, the law has tended to treat depressants as less danger-
ous than many other classes of drugs, a fact demonstrated in Part II of
267. Id. §§ 220.06, 70.00(2) (d).
268. Id. § 220.31.
269. Id. § 220.34(1)(b).
270. Id. § 220.37.
271. Id. § 220.41(3). See id. §§ 70.00(2) (a), 3(a) (ii) for the minimum sentence.
272. Reports of death from an overdose of amphetamines are rare. Ognibene, Legal Drugs,
Illegal Abuse-Amphetamines and Barbiturates, 168 New Republic, Feb. 3, 1973, at 22. That
Amphetamines do not cause physical dependence see Lingeman, supra note 21, at 6.
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this article. Two principal reasons may account for this uncharacteristic
legal response:
1. Public Acceptance
Unlike narcotic drugs which have become popularly associated with
criminal elements in society, depressants have enjoyed wide popularity
among groups at every level of the socio-economic ladder. Consequently,
no stigma or community disapproval has attached to their use. Mirroring
this public acceptance, legislatures have dealt with depressant abuse in
a relatively mild fashion, trying to contain the problem through the use
of distributive controls rather than through the use of harsh criminal
sanctions. This rather laissez faire attitude began to change during the
1960s and is slowly being replaced by a tough law enforcement approach
reminiscent of that which has characterized narcotics control since the
late 1800s.
2. Ignorance of Effects
Scientific evidence of the dangers of depressants was rather late in
coming. Not until the 1950s was it convincingly proved that depressants
lead to physical dependence if taken for too long and in too large doses.
In this regard, however, legislatures treated depressants very differently
from other drugs, such as cocaine and marihuana. Even when there was
little convincing scientific data proving cocaine and marihuana to be
dangerous, legislatures of many states and indeed Congress itself had
no qualms about outlawing their possession and sale. Whereas, in the
case of depressants, it was not until the evidence was conclusive that
legislatures finally moved to impose controls on their distribution.
Even when a tough legislative response to depressants began to take
shape in the 1960s, it was still fraught with anomalies. For example, the
Department of Justice has placed only three classes of barbiturates in
schedule II of the Controlled Substance Act, leaving most barbiturates in
schedules III and IV with little or no effective production or distribution
controls. The inevitable result of such halfhearted patchwork regulation
will be that either the market for the less tightly controlled schedule III
barbiturates will increase or a clandestine production of schedule H bar-
biturates will begin in earnest. If clandestine manufacture of barbiturates
becomes a reality, new dimensions will be added to an already difficult
drug enforcement problem. Once created, illegal manufacturing and dis-
tribution systems are hard to dismantle.
Similarly, while slow in placing meaningful controls over barbiturates,
Congress and the states have been even slower as regards the regulation
of certain minor tranquilizers. As evidence of their abuse potential grows,
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tranquilizers such as Librium and Valium have not yet appeared in any
schedule of controlled substances. The legislative reluctance to add
Librium and Valium to the schedules may stem in part from the activities
of the drug industry lobby. The more controls placed on a drug, the more
difficult it is not only to expand the size of an existing market but also
to maintain it at its present size.
Even assuming that Congress and state legislatures clear up certain
of these legislative anomalies, the successful containment of depressant
abuse will be a difficult task. Of course the experience fighting the am-
phetamine epidemic of the 1960s is instructive. When transferred from
schedule III to schedule II, amphetamines became scarce in the illegal
market. It must be remembered, however, that there are marked differ-
ences between amphetamines and barbiturates. Unlike amphetamines
which have only limited medical uses, barbiturates have a wide variety
of medical uses. As one commentator indicated: if the legitimate need
for amphetamines can be counted in the thousands of doses, the need
for barbiturates must be counted in the billions.27 3 Since so large an
amount of barbiturates must be produced to meet national medical needs,
the threat of continued illegal diversion is greater than in the case of
amphetamines. Consequently, the imposition of production quotas will
probably not reduce the availability of barbiturates on the black market
to the extent that comparable quotas reduced the availability of black
market amphetamines. Even if they did, however, clandestine production
of barbiturates would undoubtedly increase to fill the void created by
reduced legal production.
The difficulty of curtailing depressant abuse becomes more apparent
when one realizes that public opinion is more tolerant of the use of seda-
tives than of the use of most other drugs in the chemical sm6rgiisbord.
As has been seen recently with marihuana, it is difficult to prohibit the
illegal use of a substance that a large portion of society has come to
regard as safe and beneficial. Thus, while tight governmental control
over the distribution of depressants is needed in any successful strategy to
curtail their abuse, it alone will not succeed. Gradually the public must
be made aware of the dangers of depressants; gradually doctors who over-
prescribe these drugs for their patients must come to realize the dangers
inherent in such a practice; gradually with decreased availability and
increased drug education, the menace of depressant abuse may begin to
subside.
273. Ognibene, Legal Drugs, Illegal Abuse-Amphetamines and Barbiturates, 168 Now
Republic, Feb. 3, 1973, at 22.
